October 17, 2016
C-Path’s PSTC and IMI SAFE-T obtain regulatory support for new liver safety biomarkers
Related Posts
-
Understanding the Role of Patient Data in Drug Development -
eCOA Clinic #1 | Bring Your Own Device (BYOD) -
Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O). -
C-Path’s Translational Therapeutics Accelerator and Celdara Medical Announce Pipeline-focused MOU -
Successfully Navigating the Valley of Death: the Importance of Accelerators in Drug Discovery and Development